Real world use of long-acting cabotegravir and rilpivirine in a HIV centre in Hong Kong

被引：0
|
作者：
Chan, M. C. J. [1 ]
Chik, S. H. T. [1 ]
Lamb, S. S. [1 ]
Choi, Y. C. C. [1 ]
Lau, W. T. A. [1 ]
Leung, C. S. E. [1 ]
To, P. Y. L. [1 ]
Lau, P. L. D. [1 ]
Tsang, T. Y. O. [1 ]
机构：
[1] Hosp Author Infect Dis Ctr, Hong Kong, Peoples R China
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
814
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [21] Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine
    Ripamonti, Diego
    Borghetti, Alberto
    Zazzi, Maurizio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (10) : 2720 - 2724
  • [22] Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities
    Llibre, Josep M.
    Kuritzkes, Daniel A. R.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (09) : 1655 - 1657
  • [23] Use of long-acting cabotegravir plus rilpivirine during hemodialysis and solid organ transplantation
    Rezzonico, Leonardo F.
    Baldassari, Luca
    Peracchi, Francesco
    Merli, Marco
    Puoti, Massimo
    Rossotti, Roberto
    AIDS, 2023, 37 (09) : 1491 - 1493
  • [24] Long-acting rilpivirine for HIV prevention
    Jackson, Akil
    McGowan, Ian
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 253 - 257
  • [25] Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results
    Serris, Alexandra
    Ferre, Valentine Marie
    Le Hingrat, Quentin
    Bachelard, Antoine
    Charpentier, Charlotte
    Exarchopoulos, Marina
    Damond, Florence
    Phung, Bao-Chau
    Landman, Roland
    Yazdanpanah, Yazdan
    Descamps, Diane
    Joly, Veronique
    Peytavin, Gilles
    Ghosn, Jade
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (11) : 2932 - 2938
  • [26] REAL-WORLD PRESCRIBING OF LONG-ACTING INJECTABLE CABOTEGRAVIR FOR TREATMENT OF HIV IN THE UNITED STATES
    Rodriguez, P.
    Cartwright, B.
    Gratzl, S.
    Stucky, N.
    VALUE IN HEALTH, 2023, 26 (12) : S304 - S304
  • [27] Long-acting cabotegravir/rilpivirine as a safe antiretroviral therapy in solid organ transplanted HIV patients
    Moreno, Ana
    Del Campo, Santos
    Jesus Perez-Elias, Maria
    Luis Casado, Jose
    Garcia, Miguel
    Velez, Manuel
    Jesus Vivancos, Maria
    Moreno, Santiago
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 82 - 82
  • [28] Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice
    Borghetti, Alberto
    Farinacci, Damiano
    Ciccullo, Arturo
    Dusina, Alex
    Moschese, Davide
    Iannone, Valentina
    D'Angelillo, Anna
    Lombardi, Francesca
    Delle Donne, Valentina
    Massaroni, Valentina
    Visconti, Elena
    Tamburrini, Enrica
    Di Giambenedetto, Simona
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4970 - 4974
  • [29] HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program
    Masich, Anne M.
    Gomes, Denese
    Higginson, Robert T.
    Morgan, Zara
    Nixon, Daniel
    Tran, Melissa
    Winthrop, Elizabeth
    Fulco, Patricia P.
    AIDS, 2023, 37 (10) : 1641 - 1642
  • [30] An evaluation of long-acting cabotegravir plus rilpivirine for the treatment of virologically suppressed adults living with HIV
    Qazzaz, Hamdi
    Parganas, Christopher
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (13) : 1485 - 1495
12345